Biologos News

Ampersand Capital Partners Acquires Biologos

March 19, 2024

Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Biologos LLC (“Biologos”).

Read More

Biologos Attending INTERPHEX 2024

March 13, 2024

INTERPHEX NYC 2024 — Uniting industry professionals from pharmaceutical, biotech and device facilities and more. Leading global event that fuses industry innovation with expert-led technical conference.

Read More